References
- Reginato A. Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure. Sem Arthritis Rheum. 1987;17:39–57.
- Pouchot J, Sampalis JS, Beaudet F, Carette S, Decary F, Salu-sinsky SM et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine. 1991;70:118–36.
- Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992;19:424–30.
- Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum. 2001;44:550–60.
- Choi JH, Suh CH, Lee JM, Suh YJ, Lee SK, Kim SS et al. Serum cytokine profiles inpatients with adult onset Still's disease. J Rheumatol. 2003;30:2422–7.
- Chen DY, Lan JL, Lin FJ, Hsieh TY. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J Rheumatol. 2004;31:2189–98.
- Ohta A, Yamaguchi M, Tsunematsu T, Kasukawa R, Mizushima H, Kashiwagi H et al. Adult Still's disease: a multicenter survey of Japanese patients. J Rheumatol. 1990;17:1058–63.
- Kokkins A, Iliopoulos A, Greka P, Efthymiou A, Katsilambros N, Sfikakis PP. Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol. 2004;23:45–9.
- Hushi ME, Maier AL, Mease PJ, Overman SS, Fraser P, Gra-vallese EM et al. Etanercept in the treatment of adult patients with Still's disease. Arthritis Rheum. 2002;46:1171–6.
- Iwamoto M, Nara H, Hirata D, Minota S, Nishimoto N, Yoshizaki K. Humanized monoclonal anti-interleukin 6 receptor antibody for treatment of intractable adult-onset Still's disease. Arthritis Rheum. 2002;46:3388–9.
- Fautrel B, Zing E, Golmard JL, Moel GL, Bissery A, Rioux C et al. Proposal for a new set of classification criteria for adult-onset Still disease. Medicine (Baltimore) 2002;81:194–200.
- Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis. 2006;65:564–72.
- Dougados M, Awada H, Amor B. Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients. Ann Rheum Dis. 1988;47: 127–33.
- Ostensen M, Hoyeraal HM, Kass E. Tolerance of cyclosporine A in children with refractory juvenile rheumatoid arthritis. J Rheumatol. 1988;15:1536–8.
- Marchesoni A, Ceravolo GP, Battafarano N, Rossetti A, Tosi S, Fantini F. Cyclosporin A in the treatment of adult onset Still's disease. J Rheumatol. 1997;24:1582–7.
- Singh S, Samant R, Joshi VR. Adult onset Still's disease: a study of 14 cases. Cfin Rheumatol. 2008;27: 35–9.
- Park JH, Bae JH, Choi YS, Lee HS, Jun JB, Jung S et al. Adult onset Still's disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine A. J Korean Med Sci. 2004;19:137–41.
- Kam S, Andrew C, Karen R. Cyclosporin A in the treatment of adult Still's disease. J Rheumatol. 1995;22:1391–2.
- McCune WJ, Marder W, Riskalla M. Immunosuppressive drug therapy. In: Wallace DJ, Hahn BH, editors. Dubois' lupus ery-thematosus. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 1198–224.
- Maillefert JF, Duchamp 0, Solary E, Genne P, Tavernier C. Effects of cyclosporine at various concentrations on dexametha-sone intracellular uptake in multidrug resistant cells. Ann Rheum Dis. 2000;59:146–8.
- List AF, Kopecky KJ, Willman CL, Head DR, Slovak ML, Douer D et al. Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase. Blood. 2002;100:1910–2.
- Fautrel B, Borget C, Rozenberg S, Meyer 0, Loet XL, Masson C et al. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease. J Rheumatol. 1999;26:373–8.